unknown
Stage
2
Investors
About
Aperiam Bio develops hyperfolding variants of proteins using computational algorithms to improve expression, solubility, and activity, enabling the manufacture of stable enzymes and therapeutics for applications in cosmetics and pulmonary biologics.
Explore Aperiam Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.